U.S. Defense Secretary Pete Hegseth announced Wednesday that all service members aged 30 and older must undergo mandatory annual testosterone screening [1].
The initiative marks a significant shift in military medical protocols by institutionalizing hormone monitoring for a large segment of the force. By focusing on testosterone levels, the Department of Defense aims to identify and address hormonal deficiencies that could impact the readiness and long-term health of personnel.
Hegseth announced the policy from the Pentagon in Washington, D.C. He said that the goal is to provide the best possible medical care for service members and address health issues related to low testosterone [2, 3].
Under the new mandate, troops who are 30 years old or older [1] will be required to complete the screening every year [1]. For those diagnosed with low levels of the hormone, the Department of Defense will offer testosterone replacement therapy (TRT) [3]. However, the administration of this therapy remains a personal decision for the service member [3].
"We owe our warriors the absolute best medical care in the world, and this program delivers on that obligation," Hegseth said.
Regarding the optional nature of the treatment, Hegseth said, "If treatment is recommended, it's entirely your choice to receive testosterone replacement therapy."
The announcement has already drawn political criticism. Senator Cory Booker (D-NJ) responded to the news by saying that Hegseth "is not a serious person," according to CNN [4].
Despite the political friction, the Pentagon maintains that the program is a medical necessity to ensure troops receive comprehensive care [2]. The mandatory nature of the screening ensures that low testosterone, which can often go undetected without specific testing, is identified across the eligible population [1].
“"We owe our warriors the absolute best medical care in the world, and this program delivers on that obligation."”
This policy integrates endocrine health into the standard military readiness framework. By mandating screenings for those 30 and older, the Department of Defense is treating testosterone levels as a metric of physical wellness similar to cardiovascular or metabolic health. The optional nature of the subsequent therapy is likely a measure to avoid legal or ethical challenges regarding forced medical intervention, while the mandatory testing ensures a comprehensive data set on troop health.
